InSights Hub

Clinical Trials


Showing 10 results in Clinical Trials
Guidelines+ Trials Spotlight - (Tecvayli) for Patients with Newly Diagnosed Multiple Myeloma

Tecvayli Clinical Trial Results for Patients With Newly Diagnosed Multiple Myeloma – Guidelines+ Trials Spotlight

Published on

On October 25, 2022, the US Food and Drug Administration (FDA) granted approval for Johnson & Johnson’s Tecvayli® (teclistamab-cqyv) for the treatment of adult patients with relapsed or refractory multiple myeloma. This approval is specifically for patients who have previously received four or more prior lines of therapy, including a proteasome inhibitor, immunomodulatory drug, and […]

Read More
Focus
Clinical Trials
Specialties
Oncology • Pulmonology
Guidelines+ Trials Spotlight - TROPION-Lung01 Phase III trial

EGFR-Mutated NSCLC (The TROPION-Lung01 Phase III Trial) – Guidelines+ Trials Spotlight

Published on

AstraZeneca and Daiichi Sankyo have collaboratively submitted a new Biologics License Application (BLA) for accelerated approval in the United States for datopotamab deruxtecan (Dato-DXd). This application aims to provide treatment for adult patients with locally advanced or metastatic epidermal growth factor receptor-mutated (EGFR) non-small cell lung cancer (NSCLC) who have previously undergone systemic therapies, including […]

Read More
Focus
Clinical Trials
Specialties
Oncology • Pulmonology
Guidelines+ Trials Spotlight - Metastatic Squamous Cell Carcinoma of the Head & Neck (STELLAR-305)

Metastatic Squamous Cell Carcinoma of the Head and Neck (STELLAR-305) – Guidelines+ Trials Spotlight

Published on

One year ago, Exelixis commenced their phase 2/3 pivotal trial to assess the efficacy of zanzalintinib in combination with pembrolizumab compared to pembrolizumab alone in patients with previously untreated PD-L1-positive recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN). Zanzalintinib, an oral drug developed by Exelixis, targets and inhibits receptor tyrosine kinases […]

Read More
Focus
Clinical Trials
Specialties
Oncology
Guidelines + Trials Rundown Thalassemia

Thalassemia in Adults – Guidelines+ Trials Rundown

Published on

Today, we will be looking into the latest research and clinical trials focused on thalassemia in adults. The following list has been carefully curated by evaluating the ongoing phase 3 trials for thalassemia, specifically targeting adults in the United States. Please note that the dates provided are approximate and subject to change. This compilation primarily […]

Read More
Focus
Clinical Trials
Specialties
Family Medicine • Hematology • Pediatrics • Adolescent Medicine • Pediatric Hematology/Oncology
Guidelines + Trials Rundown Ulcerative Colitis

Ulcerative Colitis in Adults – Guidelines+ Trials Rundown

Published on

Today, we will be looking into the latest research and clinical trials focused on ulcerative colitis in adults. The following list has been carefully curated by evaluating the ongoing Phase 3 trials for moderately to severe ulcerative colitis, specifically targeting adults in the United States. Please note that the dates provided are approximate and subject […]

Read More
Focus
Clinical Trials
Specialties
Family Medicine • Gastroenterology
Guidelines + Trials Rundown Crohn’s Disease

Crohn’s Disease in Adults – Guidelines+ Trials Rundown

Published on

Today, we will be looking into the latest research and clinical trials focused on Crohn’s disease in adults. The following list has been carefully curated by evaluating the ongoing Phase 3 trials for Crohn’s disease, specifically targeting adults in the United States. Please note that the dates provided are approximate and subject to change. This […]

Read More
Focus
Clinical Trials
Specialties
Gastroenterology
Guidelines+ Trials Spotlight - Kisqali HR+HER2 Early Breast Cancer Results (NATALEE)

Kisqali HR+/HER2- Early Breast Cancer Results (NATALEE) – Guidelines+ Trials Spotlight

Published on

On September 17, 2024, the US Food and Drug Administration (FDA) granted approval for Novartis’s Kisqali® (ribociclib) in combination with an aromatase inhibitor (AI) for the adjuvant treatment of individuals with hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2-) stage II and III early cancer (EBC) at high risk of recurrence, including those with node-negative […]

Read More
Focus
Clinical Trials
Specialties
Oncology • Medical Oncology
Guidelines + Trials Rundown Actinic Keratosis

Actinic Keratosis in Adults – Guidelines+ Trials Rundown

Published on

Today, we will be looking into the latest research and clinical trials focused on actinic keratosis in adults. The following list has been carefully curated by evaluating the ongoing phase 3 trials for actinic keratosis, specifically targeting adults in the United States. Please note that the dates provided are approximate and subject to change. This […]

Read More
Focus
Clinical Trials
Specialties
Dermatology • Family Medicine • Internal Medicine - General
Guidelines + Trials Rundown Urinary Tract Infection (UTI)

Urinary Tract Infection (UTI) in Adults – Guidelines+ Trials Rundown

Published on

Today, we will be looking into the latest research and clinical trials focused on both uncomplicated and complicated urinary tract infections (UTIs) in adults. The following list has been carefully curated by evaluating the ongoing Phase 3 trials for UTI, specifically targeting adults in the United States. Please note that the dates provided are approximate […]

Read More
Focus
Clinical Trials
Specialties
Family Medicine • Internal Medicine - General • Urology
Guidelines + Trials Rundown: Advanced Hepatocellular Carcinoma (HCC) in Adults

Advanced Hepatocellular Carcinoma (HCC) in Adults – Guidelines+ Trials Rundown

Published on

Today, we will be looking into the latest research and clinical trials focused on advanced hepatocellular carcinoma (HCC) in adults. The following list has been carefully curated by evaluating the ongoing Phase 3 trials for HCC, specifically targeting adults in the United States. Please note that the dates provided are approximate and subject to change. […]

Read More
Focus
Clinical Trials
Specialties
Hepatology • Oncology • Medical Oncology • Radiation Oncology • Surgical Oncology
« Back to InSights Hub